Mission
To promote the use of imaging techniques in the performance of diagnostic and therapeutic procedures for the diagnosis and treatment of cancer.
IGIB promotes the integration of imaging, informatics, and interventional methods to address diverse clinical challenges such as directed biopsy and surgical resection, image-guided tumor ablation, dimensionality of scale, and targeted drug delivery. IGIB is interested in image augmentation probe development, research in probes, tissue markers, and delivery vectors for applications where imaging plays a significant role in clinical decision making.
By its very nature, image-guided interventions (IGI) encompass all aspects of imaging, from disease detection and therapy planning to response assessment and disease recurrence monitoring. Central to the IGI mission is contributing to the therapy delivery process, which can be surgery, radiotherapy, cryotherapy, targeted drug therapy, or other relevant cancer treatments. Imaging approaches in this process may involve exogeneous agents or probes intended to augment the image. Combinations of imaging methods such as optical/MRI or ultrasound/MRI are often applied for image guidance during therapy.
Staff
| Songtao Liu, PhD | Branch Chief | songtao.liu@nih.gov | 240-276-7473 |
| Bernard Dardzinski, PhD | Program Director | bernard.dardzinski@nih.gov | 240-276-7159 |
| Darrell Tata, PhD | Program Director | darrell.tata@nih.gov | 240-276-5894 |
Funded Research